We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boston Scientific Remains Optimistic, Despite Market Slumps
Boston Scientific Remains Optimistic, Despite Market Slumps
March 23, 2007
Boston Scientific’s “largest driver in financial performance” is the drug-eluting stent market, which has been softening, with “no rebound” seen yet, Chief Operating Officer Paul LaViolette said at the Lehman Brothers 10th Annual Global Healthcare Conference.